Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | +3.88% | -6.14% | -43.39% |
Financials (USD)
Sales 2024 * | 38.74M | Sales 2025 * | 50.91M | Capitalization | 71.54M |
---|---|---|---|---|---|
Net income 2024 * | -90M | Net income 2025 * | -69M | EV / Sales 2024 * | 1.85 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.41 x |
P/E ratio 2024 * |
-0.58
x | P/E ratio 2025 * |
-0.89
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.68% |
Latest transcript on Bionano Genomics, Inc.
1 day | +3.88% | ||
1 week | -6.14% | ||
Current month | +21.16% | ||
1 month | +40.59% | ||
3 months | -6.14% | ||
6 months | -35.15% | ||
Current year | -43.39% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 11-01-11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 23-09-10 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-06-30 | |
David Barker
CHM | Chairman | 82 | 10-05-10 |
Albert Luderer
BRD | Director/Board Member | 75 | 11-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 9 M€ | +10.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.07 | +3.88% | 652,999 |
24-05-23 | 1.03 | -7.21% | 1,054,591 |
24-05-22 | 1.11 | +5.71% | 1,815,891 |
24-05-21 | 1.05 | -2.78% | 703,625 |
24-05-20 | 1.08 | -5.26% | 1,225,894 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.39% | 71.54M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- BNGO Stock